FDA.reportPublic FDA data

brimonidine 0.33 % Topical Gel

RxCUI
1437707
RxNorm name
brimonidine 0.33 % Topical Gel
Display name
brimonidine 0.33 % Topical Gel
Full name
brimonidine 0.33 % Topical Gel
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:10

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MirvasoBRIMONIDINE TARTRATEGalderma Laboratories, L.P.f6a4353f-ae69-4214-901f-e5d42a6fbde72024-10-24Warnings, Adverse reactionsExact identifier
rxcui: 1437707
BRIMONIDINEBRIMONIDINEPadagis Israel Pharmaceuticals Ltdc899b329-cc5e-4443-8e94-451314de47c92024-07-31Warnings, Adverse reactionsExact identifier
rxcui: 1437707
BRIMONIDINEBRIMONIDINEBryant Ranch Prepack9f17bf0c-d880-4328-bf92-00ac81d02fd12023-02-03Warnings, Adverse reactionsExact identifier
rxcui: 1437707

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
9f17bf0c-d880-4328-bf92-00ac81d02fd1brimonidine 0.33 % Topical Gel [PSN] · brimonidine 0.0033 MG/MG Topical Gel [SCD] · brimonidine 0.33 % (as brimonidine tartrate) Topical Gel [SY]3100These highlights do not include all the information needed to use BRIMONIDINE TOPICAL GEL safely and effectively. See full prescribing information for BRIMONIDINE TOPICAL GEL . BRIMONIDINE topical gel Initial U.S. Approval: 199620230203
f6a4353f-ae69-4214-901f-e5d42a6fbde7brimonidine 0.33 % Topical Gel [PSN] · brimonidine 0.0033 MG/MG Topical Gel [SCD] · brimonidine 0.33 % (as brimonidine tartrate) Topical Gel [SY]311These highlights do not include all the information needed to use MIRVASO ® safely and effectively. See full prescribing information for MIRVASO. MIRVASO (brimonidine) topical gel Initial U.S. Approval: 199620241024
c899b329-cc5e-4443-8e94-451314de47c9brimonidine 0.33 % Topical Gel [PSN] · brimonidine 0.0033 MG/MG Topical Gel [SCD] · brimonidine 0.33 % (as brimonidine tartrate) Topical Gel [SY]34These highlights do not include all the information needed to use BRIMONIDINE TOPICAL GEL safely and effectively. See full prescribing information for BRIMONIDINE TOPICAL GEL . BRIMONIDINE topical gel Initial U.S. Approval: 199620240731